Abstract:Background: Early evaluation and treatment of patients with suspected acute coronary syndrome (ACS) poses a huge challenge to the emergency care system worldwide, but little is known about the contemporary prehospital and emergency department management of these patients. We aimed to investigate the early evaluation, treatment, and outcome of suspected ACS in a representative population of China. Methods: We did a prospective registry study involving a network of 23 emergency departments in China. Each participating site consecutively enrolled adult patients presenting with symptoms suggestive of ACS for at least 12 months between August 2015 and September 2017. All findings were weighted by sampling ratio and variation among EDs in enrollment period. Findings: A total of 13 919 patients were screened. Of those included in the analysis, mean age was 63·8±13·6 years, 57·9% were men. After symptom onset, 40·5% of the patients arrived at emergency department within two hours, and 17·9% were transported by ambulance. Upon arrival to the emergency department, 75·6% had their first ECG completed within ten minutes. Among patients without ST-segment elevation, 10·3% had serial ECGs, 56·6% had serum cardiac biomarkers measured, and 6·4% had serial cardiac biomarkers. Stress test and computed tomography angiography were rarely performed for evaluation. Among patients with ST-segment elevation, 57·3% underwent reperfusion therapy, with 51·3% receiving primary percutaneous coronary intervention and 6·3% receiving fibrinolysis. Post-hoc adjudication showed that over 60% of patients could be attributed to ACS, of which 10·2% received antiplatelet therapy prior to presentation, and by the time of emergency department disposition, 51·1% received antiplatelet therapy. Overall, the emergency department mortality rate was 0·5%, and the 30-day mortality and major adverse cardiac event rates were 3·8% and 6·8%, respectively. Interpretation: The pre-hospital and emergency department evaluation of patients with suspected ACS is insufficient in China. For those with ACS, gaps existed in the early medication and reperfusion therapy as per guidelines. These findings suggest opportunities to improve the quality of early management for suspected ACS and further reduce adverse cardiac events in China. Clinical Trial Registration Details: This study was registered at URL: https://www.clinicaltrials.gov (Unique identifier: NCT02536677). Funding Information: This work was supported by National S&T Fundamental Resources Investigation Project [2018FY100600, 2018FY100602], Shandong Provincial Natural Science Foundation [ZR2017PH070], Taishan Pandeng Scholar Program of Shandong Province [tspd20181220], Taishan Young Scholar Program of Shandong Province [tsqn20161065, tsqn201812129], Key R&D Program of Shandong Province [2020SFXGFY03, 2019GSF108073] and Qilu Young Scholar Program. Declaration of Interests: All authors declare no competing interests. Ethics Approval Statement: The study complies with the Declaration of Helsinki and was approved by the ethical committees of all participating sites. Informed consent was required from each patient to participate in the study.

The Clinical Situation of Point-of-Care Testing and Its Future Development at the Emergency Department in Shanghai

An Evaluation of Laboratory Efficiency in Shanghai Emergency by Turn Around Times Level

The Quality of POCT Ensured by the Hospital's Internal Management

Reliability and Validity of the Four-Level Chinese Emergency Triage Scale in Mainland China: A Multicenter Assessment

Evaluation of a Cardiac Troponin Process Flow at the Chest Pain Center with the Shortest Turnaround Time

Comparison of Point-of-care Testing and Laboratory Testing of Myocardial Damage Markers in the Diagnosis and Prognosis of Acute Coronary Syndrome

Point-of-care testing improves care timeliness in the emergency department. A multicenter randomized clinical trial (study POCTUR)

Does Point-of-Care Testing Impact Length of Stay in Emergency Departments (eds)?: A Before and after Study of 26 Rural and Remote EDs.

The use of a point of care high sensitivity troponin in the investigation of patients presenting to the Emergency Department with undifferentiated chest pain

Treatment delay and reperfusion management of acute ST-segment elevation myocardial infarction: analysis of the China STEMI Care Project Phase 1

Comparative Study of Laboratory Versus Bedside High-Sensitivity Troponin I in the Emergency Medicine Department of a Tertiary Care Hospital in India

Prehospital and In-Hospital Delays to Care and Associated Factors in Patients with STEMI: an Observational Study in 101 Non-Pci Hospitals in China.

Point-of-care testing with high-sensitivity cardiac troponin assays: the challenges and opportunities

Application of Remote Electrocardiogram Monitoring Systems in Chest Pain Centers for Patients with High-Risk Chest Pain.

Evaluation, Treatment, and Outcomes of Patients with Suspected Acute Coronary Syndrome in the Prehospital and Emergency Department: Findings from a Prospective Multicenter Registry in China

PCV85 EFFECT OF CHEST PAIN CENTER ON THE TREATMENT OF PATIENTS WITH ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN TIANJIN, CHINA

The Effect of Laboratory Testing on Emergency Department Length of Stay: A Multihospital Longitudinal Study Applying a Cross‐classified Random‐effect Modeling Approach

Comprehensive assessment of emergency departments in county-level public hospitals: a multicenter descriptive cross-sectional study in Henan province, China

Cardiac biomarkers by point-of-care testing – back to the future?

National survey report on the current situations and development requirements of emergency testing

Fastidious adherence to 0/1-hour high-sensitivity troponin T testing reduces emergency department length of stay in patients presenting with suspected acute coronary syndromes